Critical appraisal:Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, et al 2018 3

From Cancer Guidelines Wiki

Risk of bias assessment: Randomised Controlled Trial (Cochrane risk of bias tool)

Random sequence generation
Describe the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.Jutta's question mark icon.png
Participants were randomly assigned in a ratio of 1:1 to RT or CRT. Stratified random assignment was used to balance the arms according to high-risk nodal disease and advanced primary/in-transit disease and institution.

In cases where participants had both risk categories, patients were stratified to the high-risk nodal group.

What was the risk of bias from the random sequence generation?Jutta's question mark icon.png
High
Allocation concealment
Describe the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen in advance of or during, enrolment.Jutta's question mark icon.png
No response
What was the risk of bias from the allocation concealment?Jutta's question mark icon.png
High
Blinding
Describe all measures used, if any, to blind outcome assessors from knowledge of which intervention a participant received. Provide any information relating to whether the intended blinding was effective.Jutta's question mark icon.png
No response
What was the risk of bias from the blinding of participants and personnel and outcome assessors?Jutta's question mark icon.png
Unclear
Incomplete outcome data
Describe the completeness of outcome data for each main outcome, including attrition and exlusions from the analysis. State whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomized participants), reasons for attrition/exclusions where reported, and any re-inclusions in analyses performed by the review authors.Jutta's question mark icon.png
No response
What was the risk of bias from incomplete outcome data?Jutta's question mark icon.png
Low
Selective outcome reporting
State how the possibility of selective outcome reporting was examined by the review authors and what was found.Jutta's question mark icon.png
No response
What was the risk of bias from selective outcome reporting? Assessments should be made for each main outcome (or class of outcomes).Jutta's question mark icon.png
Low
Other sources of bias
Describe any other sources of biasJutta's question mark icon.png
No response
What was the risk of bias from other sources?Jutta's question mark icon.png
Low
Overall risk of bias
Unclear risk of bias Additional comments:


Jutta's tick icon.png This appraisal has been completed.


Article
Porceddu SV, Bressel M, Poulsen MG, Stoneley A, Veness MJ, Kenny LM, et al. Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. J Clin Oncol 2018 May 1;36(13):1275-1283 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29537906.
Assigned to
User:Albert.chetcuti
Topic area
Guidelines:Keratinocyte carcinoma
Clinical question
Form
Form:Quality appraisal rct-cochrane
Outcomes
Locoregional control; Disease-specific survival; Overall survival

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment